Image via Fortune
Last updated
Kaiser Permanente: Cybersecurity Incident
Kaiser Permanente patient suffered wrongful hysterectomy due to pathology lab sample labeling error and misidentification, resulting in false cancer diagnosis and months of unnecessary treatment
Source: Fortune
The leadership read
A breach is a governance event before it is a technical one. For Kaiser Permanente in Healthcare, the hiring consequence is rarely more engineers; it is senior accountability, security, risk and data governance reporting high enough to change decisions. Across Americas, watch whether the response is a hire or a contractor; that distinction says how the board has read it.
Market context: The wider read — a Talent Market Index of 102.5 (Warm), down 1.7 month-on-month — shows Americas signal flow easing (-2.3pts).
Kaiser Permanente: 2 signals in the last 90 days; 0.1% of MitchelLake's Americas signal flow; 3 tracked across 102 days.
Also at Kaiser Permanente →
More signals across Healthcare
Ma Activity · Americas
HCA Healthcare →HCA Healthcare acquired Texas MedClinic's urgent care clinic portfolio, expanding its nationwide urgent care footprint in response to rising consumer demand for convenient medical services.
Partnership · Americas
Cleveland Clinic →Cleveland Clinic entered into a 10-year alliance with Siemens Healthineers for imaging and therapeutic technology delivery.
Leadership Change · Americas
United States Air Force →Gen. Kenneth S. Wilsbach became Chief of Staff of the Air Force in November 2025. Under his leadership, the Air Force has shifted operational priorities toward continuous combat readiness and maintenance sustainability, with focus on spare parts availability and forward-deployed asset management in response to sustained large-scale air operations.
Ma Activity · Americas
Vertex Pharmaceuticals →Vertex Pharmaceuticals announced acquisition of Crinetics Pharmaceuticals for $10 billion, gaining approved drug Palsonify (acromegaly) and pipeline candidates including congenital adrenal hyperplasia therapy.
Leadership Change · Americas
Alkermes →Blair Jackson has joined Alkermes as incoming CEO with an explicit strategy to compete in the orexin drug market against larger competitors like Eli Lilly and Takeda. Jackson signals the next 12 months are critical for the company's competitive positioning.
Leadership Change · Americas
Takeda →Julie Kim officially appointed as Takeda's Representative Director, President and Chief Executive Officer, completing an 18-month CEO transition
Intelligence powered by Autonodal ↗